Based on NIH | Is persistent blood in urine a symptom of head and neck cancer or a complication of its treatment, and what evaluation is recommended?

Persistent blood in urine: cause and evaluation

Persistent blood in the urine (hematuria) is much more commonly a sign of a problem in the urinary tract than a direct symptom of head and neck cancer. Head and neck cancers typically cause symptoms in the mouth, throat, or neck (for example, a neck lump, mouth sore that doesn’t heal, sore throat, hoarseness, trouble swallowing), not urinary bleeding. ^{[1] [2]} However, hematuria can occur as a complication of some treatments used for head and neck cancer especially platinum-based chemotherapy (such as cisplatin or carboplatin), which can injure the kidneys and urinary tract and sometimes lead to blood in the urine. Cisplatin is well known for kidney toxicity, and patient information for common head and neck cancer regimens cautions about urine changes and blood in urine as warning signs. ^{[3] [4]} In rare cases, carboplatin has also been linked to hematuria with clot formation and obstructive kidney injury. ^[5]

Because hematuria in adults can be a warning sign of urinary tract cancer (kidney, ureter, bladder, or prostate) or other significant disease, any persistent hematuria should be evaluated systematically, regardless of cancer history. ^[6] Guidelines emphasize that gross (visible) hematuria, in particular, warrants complete urologic evaluation to rule out malignancy and other causes. ^[7]

Is it the cancer or the treatment?

• Head and neck cancer symptoms: Primarily localized to the head and neck region (neck lump, nonhealing mouth sore, hoarseness, throat pain, swallowing trouble) and do not include urinary bleeding as a typical feature. ^{[1] [2]}
• Treatment-related causes: Cisplatin can cause kidney damage (nephrotoxicity), which may present with abnormal kidney tests and sometimes hematuria; patient education materials for head and neck cancer regimens specifically advise reporting blood in urine. ^{[3] [4]} Carboplatin has rarely been reported to cause hematuria with clots and obstructive acute kidney injury. ^[5]

What conditions can cause persistent hematuria?

Persistent hematuria can arise from many sources in the urinary system. Common causes include urinary tract infections, kidney/bladder stones, kidney disease (such as glomerulonephritis), prostate enlargement, and cancers of the kidney, ureter, bladder, or prostate. ^[6] Visible blood in urine can be a sign of advanced kidney, bladder, or prostate cancer, which is why evaluation is important. ^{[8] [9]}

Recommended evaluation for persistent hematuria

A thorough, stepwise approach helps identify the source and seriousness of hematuria.

• History and physical exam
  • Clarify whether blood is visible or microscopic, timing within the urinary stream, associated pain, clots, fevers, flank pain, exercise, menstruation, medication use (especially blood thinners), and any chemotherapy exposure (cisplatin/carboplatin). ^{[10] [11]}
• Repeat urinalysis with microscopy
  • Confirm true red blood cells in urine (to exclude false positives) and check for protein, casts, or infection. ^[12]
• Urine culture and cytology when indicated
  • Culture helps exclude infection; cytology may be used when cancer risk is higher. ^[13]
• Blood tests
  • Assess kidney function (creatinine, BUN) and, when relevant, coagulation studies if bleeding risk is suspected. ^[13]
• Imaging of the urinary tract
  • CT urography is a key study for evaluating visible hematuria and can detect kidney, ureter, and bladder pathology. ^[7] Ultrasound can be considered when radiation or contrast is a concern or as an initial screen. ^[14]
• Cystoscopy
  • Direct visualization of the bladder and urethra is essential in evaluating persistent or visible hematuria, especially to rule out bladder cancer. ^[7]
• Additional procedures
  • If the cause remains unclear after CT and cystoscopy, flexible ureteroscopy can further assess the upper urinary tract. ^[7]

When urgent care is needed

Some features call for prompt medical attention:

• Visible blood with clots, inability to pass urine, severe flank/abdominal pain, fever, or signs of kidney failure. ^[7]
• During or after cisplatin-based therapy, any sudden change in urine (blood, markedly decreased output, dark urine) should be reported quickly due to risk of kidney injury. ^{[4] [3]}

How prior head and neck cancer care affects evaluation

• If you received cisplatin: Your care team should review kidney function and hydration status, and hematuria should trigger standard hematuria work‑up in addition to monitoring chemotherapy-related nephrotoxicity. ^{[3] [4]}
• If you received carboplatin: Although uncommon, drug-related hematuria has been reported; still, a full urologic evaluation is recommended to exclude other causes. ^[5]

Key takeaways

• Persistent hematuria is not a typical symptom of head and neck cancer itself but can occur as a complication of treatments like cisplatin or, rarely, carboplatin. ^{[1] [2] [4] [3] [5]}
• All adults with persistent or visible hematuria should undergo a complete urologic evaluation, including urinalysis with microscopy, appropriate urine tests, imaging (often CT urography), and cystoscopy. ^{[7] [13]}
• Because hematuria can signal urinary tract cancers, infections, stones, or kidney disease, timely assessment is important even in those with an unrelated cancer history. ^{[6] [8] [9]}

---

If you’re experiencing persistent blood in your urine, especially if you have been treated with cisplatin or carboplatin, it would be reasonable to contact your oncology and primary care teams to coordinate the urologic evaluation described above while also checking kidney function and hydration status. ^{[4] [3]}